Union members ratified an agreement on Sunday that ends a four-month-long strike by some 1,800 workers at FairPoint Communications, a major land-line telecommunications provider in northern New England, union officials announced.

Three members of the Bank of Japan's policy board expressed doubts the central bank can meet its inflation target because of a slowdown in underlying prices and falling oil, pointing to chinks in the BOJ's strategy to spark sustainable growth.

Oil prices edged up after early falls on Monday as parts of Asia returned from the Lunar New Year holiday, with Brent futures moving further away from $60 a barrel and U.S. contracts moving towards $51.

Chinese auto parts maker Wanxiang Group (000559.SZ) will push back its planned relaunch of the defunct Fisker Karma hybrid sports car until mid-2016 and rebrand Fisker Automotive as Elux, two sources familiar with the plan said Sunday.

Rupert Murdoch's Twenty-First Century Fox Inc held preliminary takeover talks with Discovery Communications Inc with a view to creating a $100 billion entertainment giant, the Australian Financial Review reported on Monday.

Stock markets and the euro started the week on a cautious note on Monday as a Greek debt deal struck last week remained in the balance until Athens drew up a list of reforms to satisfy its creditors.

With the joint partnership of Ubisoft and Regency Company, the much awaited video game film, "Assassin's Creed" will start its production. Actress Marion Cotillard joins the Assassin's Creed project, along with screenwriter Scott Frank who was tapped to do a rewrite for the long-stalled adaptation.

The weak global diary market, hit by oversupply and a tail-off in Chinese demand that has driven international milk prices down by around 50 percent, is unlikely to pick up anytime soon, analysts say.

Daimler AG's (DAIGn.DE) Mercedes-Benz is recalling more than 147,000 mid-size sedans and station wagons from 2013-2015 to check for risk of engine fires, the U.S. safety regulator said Saturday.

Canada's Valeant Pharmaceuticals International Inc. agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd. (SLXP.O) in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.